Nouvelles

BEIJING, AUGUST 24, 2021 - Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu Medical”), a leading global company specialized in developing, manufacturing and marketing high-tech medical devices and equipment, today announced that its Seringue stérile pour la ligne à usage unique Obtenu l'approbation de marquage CE pour un usage général, y compris la livraison de divers vaccins COVID-19.

Le marquage CE indique que la seringue stérile à usage unique de Lepu Medical répond aux normes de la catégorie de l'Union européenne (UE) en matière de sécurité et de performance pour une utilisation par les professionnels de la santé pour l'aspiration et l'injection de fluides à usage général, ce qui les rend disponibles pour un achat professionnel dans toute l'UE et dans d'autres pays qui reconnaissent le marquage CE.

Lepu Medical’s Seringue stérile pour la ligne à usage unique has received CE Mark approval at a time of high-demand for needles suitable to vaccinate populations against the COVID-19 pandemic.  Lepu Medical’s syringe series offers a variety of single-use needles for many applications, including various COVID-19 vaccines. The line includes both Luer Lock and Lock Slip syringes, a clear barrel, plunger, plunger stopper, needle, and cap. Lepu Medical’s syringe series offers a higher resistance to breakage in single-use, and latex-free pistons. The total graduated capacity of all models of syringes is 1mL, with a range of needle sizes to meet a variety of injection and COVID-19 vaccine needs, each distinguished by the color of the needle hub.

Designed to meet a variety of injection needs, Lepu Medical’s Sterile Syringe For Single-Use brings improved safety to patients and doctors with its clear barrel for convenient control of foreign substances. The Sterile Syringe For Single-Use is intended only for one-time use by  healthcare professionals who have received training on medical injection techniques. Injection and vaccine administrators can refer to the Lepu Medical professional manual before use for a full understanding of the device instructions, warnings and precautions.

En plus de la seringue stérile à usage unique, Lepu Medical a fourni diverses fournitures médicales pour la prévention et le contrôle des COVID-19, y compris le kit de test rapide de l'antigène SARS-CoV-2 pour l'auto-test et le kit de test d'anticorps SARS-CoV-2 pour les tests professionnels de la santé. Lepu Medical propose également des solutions de diagnostic COVID-19 telles que des produits et des solutions d'acide nucléique pour fournir des tests standard pour diagnostiquer les COVID-19, et des produits de test d'anticorps pour surveiller les niveaux d'immunité COVID-19. Les autres produits et solutions COVID-19 de Lepu Medical comprennent des kits de prélèvement d'échantillons, des kits d'extraction d'échantillons manuels, des extracteurs d'échantillons automatisés et des systèmes PCR en temps réel pour le diagnostic clinique standard des acides nucléiques.

As of August 2021, the number of global daily doses of COVID-19 vaccines continues to rise, driving demand for vaccines and vaccination supplies. According to published statistics, by the end of 2020, major governments had placed purchases for over nine billion vaccine units. With the onset of the Delta virus, vaccination rates are ramping up and the expected number of vaccine units is increasing. Government officials and medical professionals across the globe from Israel, France, Germany, the U.S, the United Arab Emirates, Bahrain, the United Kingdom, Switzerland, Cambodia and others are proposing and actively preparing for the third dose of the COVID-19 vaccination to strengthen pandemic prevention and control efforts. With the CE Mark approval for the Sterile Syringe For Single-Use, Lepu Medical will continue to proactively seek qualified partners to support the availability of reliable vaccine supplies across the globe, and assist with COVID-19 management and continuation of general medical practices.